PDE2/PDE10-IN-1 is a potent inhibitor of phosphodiesterases PDE2 and PDE10, with IC50 values of 29 nM and 480 nM, respectively; it is used as a pharmacological tool for studying PDE2 and PDE10 functions; demonstrates good oral bioavailability and brain penetration, supporting its potential application in central nervous system (CNS)-related research; exhibits an ED50 of 21 mg/kg for PDE2 occupancy in vivo, indicating its utility in target engagement studies.